Aytu BioScience Announces Positive Results from an Independently Conducted Clinical Study of the Company’s Licensed COVID-19 IgG/IgM Point-of-Care Rapid Test
Independent clinical study demonstrates test accuracy of 98.0% and 94.1% for IgG and IgM, respectively, when using PCR-positive cases as...